ASX treatment was also reported to ameliorate insulin resistance and improve insulin signaling by activating post-receptor insulin signaling [85,112], to reduce the oxidative stress produced by various stimuli including TNF-α [111], and to inhibit pro-inflammatory cytokines in obese mice [85,110]. The gene discussed is INS; the disease is Insulin resistance.